EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Early-Stage Pancreatic Cancer Diagnosis: Serum Biomarkers and the Potential for Aptamer-Based Biosensors

Weisi He iD, Jingyu Cui iD, Xue-Yan Wang iD, Ryan H P Siu iD, Julian A Tanner iD

Molecules · 30.04.2025 · 30 (9) · 2012

DOI: 10.3390/molecules30092012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 30.04.2025. Verfasst von Weisi He und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Biomarkers, Tumor, Biosensing Techniques, Aptamers, Nucleotide. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Research Fund (GRF) grants, Innovation and Technology Commission Public Sector Trial Scheme for the Prevention and Con-trol of COVID-19 in Hong Kong "COVID-19 Point-of-Care Diagnostics in…, HKU Seed Funding for Translational and Applied Research 2020/21 "Digital Diagnostics Using CRISPR-Enabled Nucleic Acid Probe Platform".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer has a high mortality rate, and both the incidence and mortality are continuing to increase in many countries globally. The poor prognosis of pancreatic cancer is in part due to the challenges in early diagnosis. Improving early-stage pancreatic cancer diagnosis would improve survival outcomes. Aptamer-based biosensors provide an alternative technological approach for the analysis of serum biomarkers with several potential advantages. This review summarizes the major pancreatic cancer serum biomarkers, as well as discusses recent progress in biomarker exploration and aptasensor development. Here, we review both established and novel serum biomarkers identified recently, emphasizing their potential for early-stage pancreatic cancer diagnosis. We also propose strategies for further expanding multiplex biomarker panels beyond the established CA19-9 biomarker to enhance diagnostic performance. We discuss technological advancements in aptamer-based sensors for pancreatic cancer-related biomarkers over the last decade. Optical and electrochemical sensors are highlighted as two primary modalities in aptasensor design, each offering unique advantages. Finally, we propose steps towards clinical application using aptamer-based sensors with multiplexed biomarker detection for improved pancreatic cancer diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsBiomarkers, TumorBiosensing TechniquesAptamers, NucleotideEarly Detection of CancerHumans

Stichwörter der Autor:innen

aptamerbiomarkerearly-stage pancreatic cancer diagnosissensor

Substanzen

Biomarkers, TumorAptamers, Nucleotide

Autor:innen und Institutionen

  • School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Advanced Biomedical Instrumentation Centre, Hong Kong Science Park, Hong Kong SAR, China.
  • Materials Innovation Institute for Life Sciences and Energy (MILES), HKU-Shenzhen Institute of Research and Innovation (HKU-SIRI), Shenzhen 518057, China.

ORCID-Profile: Weisi He, Jingyu Cui, Xue-Yan Wang, Ryan H P Siu, Julian A Tanner

Förderung

  • General Research Fund (GRF) grants
  • Innovation and Technology Commission Public Sector Trial Scheme for the Prevention and Con-trol of COVID-19 in Hong Kong "COVID-19 Point-of-Care Diagnostics in…
  • HKU Seed Funding for Translational and Applied Research 2020/21 "Digital Diagnostics Using CRISPR-Enabled Nucleic Acid Probe Platform"
  • HKU Seed Funding for Translational and Applied Research 2023/24 "Development of an organic electrochemical transistor-based electrochemical aptamer biosensor"
  • Hong Kong University Grants Council Theme-based Research Scheme
  • General Research Fund (GRF)
  • HKU Seed Funding for Translational and Applied Research 2020/21
  • HKU Seed Funding for Translational and Applied Research 2023/24

Zitieren

APA

He, W., Cui, J., Wang, X. Y., Siu, R. H. P., & Tanner, J. A. (2025). Early-Stage Pancreatic Cancer Diagnosis: Serum Biomarkers and the Potential for Aptamer-Based Biosensors. Molecules, 30(9), 2012. https://doi.org/10.3390/molecules30092012

Vancouver

He W, Cui J, Wang XY, Siu RHP, Tanner JA. Early-Stage Pancreatic Cancer Diagnosis: Serum Biomarkers and the Potential for Aptamer-Based Biosensors. Molecules. 2025;30(9):2012. doi:10.3390/molecules30092012

BibTeX
@article{He2025,
  author = {He, Weisi and Cui, Jingyu and Wang, Xue-Yan and Siu, Ryan H P and Tanner, Julian A},
  title = {Early-Stage Pancreatic Cancer Diagnosis: Serum Biomarkers and the Potential for Aptamer-Based Biosensors},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {9},
  pages = {2012},
  doi = {10.3390/molecules30092012}
}
Kostenlos starten →